ScholarIQanswers from OpenAlex

Oral tacrolimus long‐term therapy in patients with Crohn’s disease and steroid resistance

PaperCitations, authors & open-access status

Oral tacrolimus long‐term therapy in patients with Crohn’s disease and steroid resistance is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Oral tacrolimus long‐term therapy in patients with Crohn’s disease and steroid resistance have?

ScholarIQcitation count

Oral tacrolimus long‐term therapy in patients with Crohn’s disease and steroid resistance has 76 citations in the OpenAlex counts ScholarIQ stores.

When was Oral tacrolimus long‐term therapy in patients with Crohn’s disease and steroid resistance published?

ScholarIQyear

Oral tacrolimus long‐term therapy in patients with Crohn’s disease and steroid resistance has 2001 year in the ScholarIQ index.

What is the open-access status of Oral tacrolimus long‐term therapy in patients with Crohn’s disease and steroid resistance?

ScholarIQoa status

Oral tacrolimus long‐term therapy in patients with Crohn’s disease and steroid resistance has bronze oa status in the ScholarIQ index.

What is the DOI of Oral tacrolimus long‐term therapy in patients with Crohn’s disease and steroid resistance?

ScholarIQdoi

The DOI for Oral tacrolimus long‐term therapy in patients with Crohn’s disease and steroid resistance is on the source record.

What is the PMID of Oral tacrolimus long‐term therapy in patients with Crohn’s disease and steroid resistance?

ScholarIQpmid

The PMID for Oral tacrolimus long‐term therapy in patients with Crohn’s disease and steroid resistance is on the source record.

What is the OpenAlex record for Oral tacrolimus long‐term therapy in patients with Crohn’s disease and steroid resistance?

ScholarIQopenalex

The OpenAlex for Oral tacrolimus long‐term therapy in patients with Crohn’s disease and steroid resistance is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial